Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

New research presents promising findings on colorectal cancer treatment and prevention

by
June 2, 2025
in Health Care
0
New research presents promising findings on colorectal cancer treatment and prevention

See all topics

Email
Link Copied!

Colorectal cancer is the second most common cause of cancer deaths in the United States, according to the American Cancer Society. This year, the organization estimates that more than 150,000 Americans will be diagnosed with it and nearly 53,000 will die from it.

New studies presented at the annual meeting of the American Society of Clinical Oncology, or ASCO, in the last few days offer promising findings for both pharmaceutical and lifestyle interventions, including the impact of diet and exercise.

Diagnoses of colorectal cancer have been decreasing overall for decades, the American Cancer Society says, thanks in large part to better screening. But case rates are rising among younger adults, and research estimates that colorectal cancer will become the leading cause of cancer death among adults ages 20 to 49 by 2030.

Earlier research has suggested that regular exercise can improve survival rates for colorectal cancer patients, and a new study – published in the New England Journal of Medicine and presented at the ASCO conference on Sunday – confirmed those findings with robust clinical trial data.

Related article
Female cancer patient looking away while sitting at home

The Good Brigade/Digital Vision/Getty Images

Cancer cases in younger people are rising sharply. Here are some preventive measures to take

Between 2009 and 2024, researchers followed nearly 900 colon cancer patients who had completed chemotherapy – half of whom received an informational booklet that encouraged them to adopt a healthy lifestyle with good nutrition and exercise the other half of whom were also matched with a physical activity consultant for three years.

They found that there was a 28% reduction in the risk of recurrence or new cancer for patients on the exercise program, with a five-year disease-free survival rate of 80% for the group with an exercise consultant compared with 74% for the group who just received the booklet.

In other words, the exercise program was found to prevent 1 out of every 16 patients from developing recurrent or new cancer.

“That magnitude is comparable to – and in many cases exceeds – the magnitude of benefit offered by a lot of our very good standard cancer drugs,” said Dr. Christopher Booth, a professor of oncology with Queen’s University and co-author of the new study. “Exercise really should be considered an essential component of treatment of colon cancer.”

Work is still being done to understand why exercise can help reduce the risk of cancer, but experts say that it may have something to do with the ways exercise helps reduce inflammation in the body.

Another new study presented at the ASCO conference on Sunday found that anti-inflammatory diets also helped improve survival rates for people with stage 3 colon cancer.

Patients who consumed more anti-inflammatory diets – including coffee, tea and vegetables such as leafy greens – and engaged in higher levels of physical activity had a 63% lower risk of death compared to patients who consumed the most inflammatory diets – including things like red meat, processed meat, refined grains and sugar-sweetened beverages – and engaged in lower levels of physical activity, the study found.

An anti-inflammatory diet, often filled with leafy greens and other vegetables, can be a helpful intervention to lower colorectal cancer risk, according to a new study.

Ekaterina Smirnova/Moment RF/Getty Images

“Actively, as a field, we’re learning about the role of the immune system in cancer development, and inflammation is an immune response,” said Dr. Sara Char, a clinical fellow in Hematology and Oncology at Dana-Farber Cancer Institute and lead author of the study, and the rise of colorectal cancer cases in younger people suggests it’s a critical piece of the puzzle.

“When we look at the incidence of colon cancer in younger individuals … that really suggests to us that there is something in the environment – either in the foods we eat, our lifestyles, the chemicals that could be in our foods, all sorts of different things – that are outside of just genetics alone that could be driving these rates,” she said. “So it is incredibly important for us, as a field, to be thinking about how our diet and lifestyle impacts not just our risk of developing this cancer, but then how people fare after it.”

Both Booth and Char said that colorectal cancer patients are often seeking ways to proactively manage their risk.

“I think that’s it’s very empowering for patients,” Booth said. “It’s also achievable for patients. This is a commitment, but it’s something that patients can achieve.”

In his study, an “exercise prescription” was developed based on each individual’s starting point. Most people were able to reach their target increase if they went for a brisk walk for about an hour three or four days per week, Booth said.

Lifestyle interventions like exercise and diet are also “sustainable for health systems,” he said, but it’s key that the system helps support patients in accessing the resources needed for behavioral interventions.

Related article
Dr. Albert Bourla, Chairman and CEO, Pfizer speaks onstage during The Wall Street Journal’s 2024 The Future Of Everything Festival at Spring Studios on May 22, 2024 in New York City.

Dia Dipasupil/Getty Images

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’

Another new study showed promising results that might represent a new standard-of-care for certain patients with advanced colon cancer.

On Friday, drugmaker Pfizer presented data on a colorectal cancer drug, Braftovi, used in combination with a standard chemotherapy and an antibody drug. During the trial, the drug combo was shown to double the length of time patients with an aggressive form of colorectal cancer lived with treatment: an average of 30 months compared with 15 months using currently available treatments.

Braftovi targets a mutation in a specific protein that can lead to abnormal cell growth, and it’s already approved by the US Food and Drug Administration to treat some forms of cancer. The study, which was funded by Pfizer, published Friday in the New England Journal of Medicine.

The latest data on treatment for colorectal cancer a “very, very important finding,” Bourla said, and the drugmaker plans to seek additional approval to add the new indication to the drug’s label.

This post appeared first on cnn.com
Previous Post

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’

Next Post

RFK Jr. fires ‘opening salvo’ on vaccine status quo

Next Post
RFK Jr. fires ‘opening salvo’ on vaccine status quo

RFK Jr. fires 'opening salvo' on vaccine status quo

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    Biden’s HHS Secretary condemns Trump admin: ‘This is how public health collapses’

    Biden’s HHS Secretary condemns Trump admin: ‘This is how public health collapses’

    June 5, 2025
    WH budget chief pressed on PEPFAR funds, says Africa ‘needs to absorb more of the burden’

    WH budget chief pressed on PEPFAR funds, says Africa ‘needs to absorb more of the burden’

    June 4, 2025
    Top CDC COVID vaccine advisor resigns following RFK Jr. recommendation change

    Top CDC COVID vaccine advisor resigns following RFK Jr. recommendation change

    June 4, 2025

    Trending

    Democrats warn of ‘largest Medicaid cut in American history’

    Democrats warn of ‘largest Medicaid cut in American history’

    February 25, 2025
    Senate Democrat unveils legislation giving FDA oversight on CBD safety standards

    Senate Democrat unveils legislation giving FDA oversight on CBD safety standards

    September 25, 2024
    Dementia cases expected to double by 2060: Study

    Dementia cases expected to double by 2060: Study

    January 14, 2025
    Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk

    Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk

    May 20, 2025

    Recent News

    Biden’s HHS Secretary condemns Trump admin: ‘This is how public health collapses’

    Biden’s HHS Secretary condemns Trump admin: ‘This is how public health collapses’

    June 5, 2025
    WH budget chief pressed on PEPFAR funds, says Africa ‘needs to absorb more of the burden’

    WH budget chief pressed on PEPFAR funds, says Africa ‘needs to absorb more of the burden’

    June 4, 2025

    Popular News

    • Biden’s HHS Secretary condemns Trump admin: ‘This is how public health collapses’
    • WH budget chief pressed on PEPFAR funds, says Africa ‘needs to absorb more of the burden’

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.